Caribou Biosciences (CRBU) has a market capitalization of $126.8M, based on 89.92M shares at a price of $1.41 (up 1.1% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
February 2025 | $1.43 | 12,883,737 | 89,919,463 | $128,584,832.09 |
January 2025 | $1.43 | 33,066,614 | 89,919,463 | $128,584,832.09 |
December 2024 | $1.59 | 30,636,499 | 90,455,900 | $143,824,881.00 |
November 2024 | $2.19 | 38,472,382 | 90,455,900 | $198,098,421.00 |
October 2024 | $1.96 | 21,097,390 | 90,455,900 | $177,293,564.00 |
September 2024 | $1.96 | 20,119,656 | 90,455,900 | $177,293,564.00 |
August 2024 | $2.16 | 19,496,674 | 90,455,900 | $195,384,744.00 |
July 2024 | $2.32 | 47,317,633 | 90,455,900 | $209,857,688.00 |
June 2024 | $1.64 | 65,872,492 | 90,340,900 | $148,159,076.00 |
May 2024 | $2.88 | 48,990,594 | 90,340,900 | $260,181,792.00 |
April 2024 | $3.63 | 35,472,326 | 90,340,900 | $327,937,467.00 |
March 2024 | $5.14 | 36,561,743 | 89,302,900 | $459,016,906.00 |
February 2024 | $7.91 | 28,631,820 | 89,302,900 | $706,385,939.00 |
January 2024 | $6.13 | 33,403,594 | 89,302,900 | $547,426,777.00 |
December 2023 | $5.73 | 34,195,337 | 88,432,900 | $506,720,517.00 |
November 2023 | $5.87 | 40,536,162 | 88,432,900 | $519,101,123.00 |
October 2023 | $3.63 | 25,547,800 | 88,432,900 | $321,011,427.00 |
September 2023 | $4.78 | 39,935,828 | 83,784,000 | $400,487,520.00 |
August 2023 | $5.89 | 30,411,830 | 83,784,000 | $493,487,760.00 |
July 2023 | $7.19 | 151,886,051 | 83,784,000 | $602,406,960.00 |
June 2023 | $4.25 | 22,778,654 | 61,417,900 | $261,026,075.00 |
May 2023 | $4.41 | 14,619,638 | 61,417,900 | $270,852,939.00 |
April 2023 | $4.30 | 10,494,443 | 61,417,900 | $264,096,970.00 |
March 2023 | $5.31 | 12,140,320 | 61,186,500 | $324,900,315.00 |
February 2023 | $6.09 | 7,807,580 | 61,186,500 | $372,625,785.00 |
